Strs Ohio Brooklyn Immuno Therapeutics, Inc. Transaction History

Strs Ohio

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$0.48 - $2.03 $3,264 - $13,803	-6,800 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$8.86 - $17.05 $11,518 - $22,165	1,300 Added 23.64%	6,800 $63,000
Q2 2021 Jul 26, 2021	BUY	$3.75 - $78.5 $20,625 - $431,750	5,500 New	5,500 $99,000

1.21M

Ticker BTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,825,700
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.